cme group inc (CME) Key Developments
CME Group Inc. Expands OTC Agricultural Offering with New USD-Denominated Palm Oil Swap
May 20 13
CME Group Inc. announced it has expanded its centrally cleared, over-the-counter (OTC) agricultural swap offering through the introduction of a new USD denominated palm oil swap. Pending CFTC review, the new USD Malaysian Crude Palm Oil Calendar Swap will be available for clearing on CME ClearPort on June 3, and will be listed with and subject to the rules and regulations of the CBOT. The USD Malaysian Crude Palm Oil Calendar Swap is based on prices from Bursa Malaysia Derivatives Crude Palm Oil futures contract.
CME Group Inc. Reports Consolidated Earnings Results for the First Quarter Ended March 31, 2013; Reaffirms Capex Guidance for the Year of 2013
May 2 13
CME Group Inc. reported consolidated earnings results for the first quarter ended March 31, 2013. For the quarter, the company reported revenues of $719 million and operating income of $406 million compared to revenues of $774.6 million and operating income of $451.2 million reported a year ago. Net income attributable to the company was $236 million or $0.71 per diluted share compared to $266.6 million or $0.80 per diluted share reported a year ago. On a non-GAAP basis, diluted EPS would have been $0.73. Income before income taxes was $387.6 million compared to $433.4 million reported a year ago. Adjusted net income attributable to the company was $244.4 million.
For the second quarter, the company expects interest expense to be likely between $26 million and $27 million. CapEx guidance remains between $140 million and $150 million.
CME Group Presents at GAI AgTech Investment Summit, Apr-29-2013 02:30 PM
Apr 27 13
CME Group Presents at GAI AgTech Investment Summit, Apr-29-2013 02:30 PM. Venue: New York, United States. Speakers: Bluford H Putnam, Chief Economist & Managing Director.
CME Group Inc. Announces New Futures Contracts for Renewable Identification Numbers (RINs)
Apr 25 13
CME Group Inc. announced the launch of nine new futures contracts for Renewable Identification Numbers (RINs). These contracts will be listed with, and subject to, the rules and regulations of NYMEX. The new RINs contracts will be available for trading starting May 13, 2013, and will allow customers to hedge risk in three types of renewable fuels: D4 Biodiesel; D5 Advanced Biofuel and D6 Ethanol. These contracts will be financially-settled based on Argus Media's prices for RINs, which are the most widely-used indexes for this market. They will provide a useful hedge for the price risk associated with the U.S. Environmental Protection Agency's (EPA) renewable fuel standard (RFS2). The EPA has created a credit trading system for compliance with RFS2 for various types of renewable fuels based on units called RINs. These contracts will be available on the CME Globex electronic trading platform, for over-the-counter (OTC) clearing through CME ClearPort and open outcry on the trading floor in New York, beginning with the May 2013 contract month.
Cme Group Inc. Approves Amendment to Bylaws
Apr 23 13
On April 17, 2013, the Board of Directors of CME Group Inc. approved the Tenth Amended and Restated Bylaws. The primary purpose of the amendments was to implement a majority voting policy, as permitted under Delaware law, for the election of directors. In connection with the approval of the amendments to the Bylaws, the Board also approved changes to its Corporate Governance Principles to provide that an incumbent director who fails to receive the required number of votes for re-election in accordance with the Bylaws shall offer to resign. In such event, the Governance Committee will make a recommendation to the Board as to whether to accept or reject the tendered resignation, or whether other action should be taken. The Board will act on the tendered resignation, taking into account the Governance Committees recommendation, and will publicly disclose its decision regarding the resignation within ninety (90) days after the results of the election are certified. If the resignation is not accepted, the director will continue to serve until the next annual meeting of shareholders and until the directors successor is elected and qualified. The amendments to the Bylaws also included changes to Section 5.1 and to Section 8.1 to reflect the company's current officer composition and to incorporate the Boards right to elect a Lead Director.